Why some brain tumors respond to immunotherapy

(Columbia University Irving Medical Center) Fewer than 1 in 10 patients with glioblastoma -- the most common type of brain cancer -- respond to immunotherapy; a new study reveals how to detect patients who may respond.

Source: EurekAlert! - Cancer - February 15, 2019 Category: Cancer & Oncology Source Type: news